While the impact of GLP-1 RAs on cardiovascular outcomes has been shown to be directly correlated with the reduction in A1c, these agents exhibit pleiotropic effects [54]
Combined sodium-glucose-transporters inhibitors and glucagon-like-peptide receptor agonist compared with monotherapy improves long-term survival: a real-world registry
10.1016/j.bbrc.2021.02.065 93 ZhangZ.MaY.XieC.HeY.WangD.SongH.et al (2025)
As research progresses, GLP-1 will likely become an integral part of weight loss plans
Hims & Hers Selling GLP-1 Injection That's Not FDA Approved, From Shady Supplier And Won't Make You Talk to a Doctor to Get It Based on Hunterbrook Medias reporting, Hunterbrook Capital is short $HIMS
According to Drucker the findings, published in December 2023, provided the first demonstration of 'a GLP-1-brain-immune axis that controls inflammation across the body independent of weight loss, even in peripheral organs devoid of GLP1 receptors.' Drucker's team has not yet identified which particular brain cells interact with GLP-1 (AAAS)
